Stockscreener 앱 받기
0.8133
2.83%
-0.0237
시간 외 거래:
.83
0.0167
+2.05%
Hyperfine Inc 주식(HYPR)의 최신 뉴스
HYPR Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Hyperfine Forms Global Neurosurgery Advisory Council - Medical Product Outsourcing
Hyperfine, Inc. to Participate in Lake Street Capital Markets 10th Annual Best Ideas Growth Conference - Yahoo Finance
Hyperfine reports 3,000 scans completed in first office year By Investing.com - Investing.com Canada
Hyperfine reports 3,000 scans completed in first office year - Investing.com
Hyperfine (HYPR) Earnings Update: The Available Earnings Metric Delivers a Beat at the Close; Market Response: Shares Finish 4.21% Down for the Current SessionEnergy Earnings Report - vinanet.vn
HYPR | Hyperfine, Inc. Class A FinancialsRevenue Breakdown - Quiver Quantitative
Hyperfine (HYPR) Q2 2026 Earnings Call Transcript - AOL.com
BTIG reiterates Hyperfine stock rating on FDA software clearance By Investing.com - Investing.com Canada
BTIG reiterates Hyperfine stock rating on FDA software clearance - Investing.com
Hyperfine Wins FDA Clearance for Next Optive AI Software - Medical Product Outsourcing
Hyperfine receives FDA clearance for Swoop MRI software update - Investing.com
Hyperfine receives FDA clearance for Swoop MRI software update By Investing.com - Investing.com South Africa
Hyperfine Announces FDA Clearance of the Next Optive AI™ Software, Further Enhancing Image Quality, Clinical Utility, and Ease of Use of the Swoop® System Across Care Settings - Business Wire
Hyperfine, Inc. (NASDAQ:HYPR) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
Hyperfine Inc. (HYPR) Q2 2026 Earnings: Narrower Loss Beats Estimates, Shares Edge LowerEarnings Momentum Score - vinanet.vn
HYPR Q2 2026 Earnings: Narrower Loss Beats Estimates as Shares SlipEarnings Stability Report - vinanet.vn
Hyperfine Inc. (HYPR) Edges Lower to $0.9 as Shares Trade Within Narrow RangeLiquidity Order Flow - vinanet.vn
Hyperfine, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:HYPR) 2026-08-10 - Seeking Alpha
HYPR Reiterates by B. Riley Securities -- Price Target Lowers to $1.60 - GuruFocus
B. Riley Financial Reaffirms Buy Rating for Hyperfine (NASDAQ:HYPR) - MarketBeat
HYPR Q2 2026 Earnings: Narrower-Than-Expected Loss Lifts Shares 2.83%EPS Growth Report - vinanet.vn
Hyperfine Q2 2026 slides: 45% revenue growth, AI-powered MRI expansion - Investing.com Australia
Hyperfine Inc (HYPR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Hyperfine Touts Positive Results From Portable MRI Study - Medical Product Outsourcing
Hyperfine, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Hyperfine (NASDAQ:HYPR) Announces Quarterly Earnings Results - MarketBeat
Hyperfine Q2 Earnings Call Highlights - MarketBeat
Earnings call transcript: Hyperfine’s Q2 2026 revenue rises 45% but misses estimates - Investing.com
Hyperfine, Inc. (HYPR) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
Hyperfine : Quarterly Report for Quarter Ending June 30, 2026 (Form 10-Q) - marketscreener.com
Hyperfine (HYPR) Releases Q2 2026 Earnings: Revenue Growth but EPS in Line - Quiver Quantitative
Hyperfine Q2 2026 earnings: Revenue rises 45% as operating loss narrows - TradingKey
Hyperfine, Inc. Q2 2026: Revenue $3.904M, EPS $(0.09) — 10-Q Summary - TradingView
Portable MRI maker Hyperfine's Q2 revenue rises less than expected - TradingView
Hyperfine, Inc. (HYPR) Q2 FY2026 earnings call transcript - Yahoo Finance
Hyperfine reports Q2 2026 revenue $3.9M, net loss $9.3M, expands international approvals - TradingView
Hyperfine, Inc. (NASDAQ: HYPR) grows Q2 sales but remains unprofitable - Stock Titan
Hyperfine, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Hyperfine (Nasdaq: HYPR) grows Q2 2026 revenue 44.8% as cash rises to $43.5M - Stock Titan
HYPR: Q2 2026 delivered robust revenue growth, margin expansion, and accelerated global adoption - TradingView
BRIEF-Hyperfine, Inc. Q2 EPS USD -0.09 - TradingView
Hyperfine, Inc. Reports Second Quarter 2026 Financial Results - Business Wire
Hyperfine Inc (HYPR) (Q2 2026) Earnings Call Highlights: Revenue Surges 45% on Strong System ... By GuruFocus - Investing.com Canada
Earnings To Watch: Hyperfine Inc (HYPR) Q2 2026 -- GF Value Sees 72% Upside - Yahoo Finance
Hyperfine Inc. (HYPR) Climbs to $1.03 as Bullish Traders Test ResistanceGolden Cross - dars.gov.et
Hyperfine Inc expected to post a loss of 9 cents a shareEarnings Preview - TradingView
Hyperfine, Inc. Revenue Breakdown – NASDAQ:HYPR - TradingView
Hyperfine Inc. (HYPR) Gains 4.15% as Stock Tests Key Resistance at $0.98MFI Oversold - dars.gov.et
Hyperfine’s portable MRI system featured in medical journals - Investing.com
Hyperfine Inc. (HYPR) Q1 2026 Earnings: Narrower Loss Beats Estimates, Shares SlideEPS Surprise History - vinanet.vn
New Hyperfine Swoop® Portable MRI for Easier and Faster Stroke Visualization - marketscreener.com
HYPR|Hyperfine Inc|Price:0.936|Chg%:+0.008 - TradingKey
Hyperfine Inc (HYPR) Institutional Confidence - TradingKey
Hyperfine Inc (HYPR) Balance Sheet - TradingKey
HYPR|Hyperfine Inc|Price:0.970|Chg%:+0.016 - TradingKey
Hyperfine Inc (HYPR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Hyperfine Inc (HYPR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Hyperfine Inc (HYPR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Hyperfine Inc (HYPR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
0.86%
0.13%
자본화:
|
볼륨(24시간):